Inspira Technologies Oxy BHN Ltd

Inspira Technologies Oxy B.H.N. Ltd. is engaged in research, development, manufacture, and marketing of proprietary respiratory support technology. The firm seeks to provide alternative to invasive mechanical ventilation. The company was founded by Dagi Ben Noon, Joe Hayon, and Dr. Udi Nussinovitch in July 2017 and is headquartered in Raanana, Israel.

Earnings data Q3 2021

Earnings data Q4 2021

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Inspira Technologies Oxy B.H.N. Ltd. is a specialty medical device company, which engages in research, development, manufacturing, and marketing of proprietary life support technology with a vision to supersede traditional mechanical ventilators, or Mechanical Ventilation, which is the standard of care today for the treatment of acute respiratory failure. The company was founded by Dagi Shahar Ben Noon, Joe Hayon, and Udi Nussinovitch in July 2017 and is headquartered in Raanana, Israel.

All 20 claims were found to be novel, with inventive step and industrial applicability RA'ANANA, Israel , Jan. 23, 2023 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, announced today that the novel convertible dual lumen cannula device and method of use, being developed for the INSPIRA™ ART System, has been granted a patent by the U.S. Patent and Trademark Office (USPTO).

Inspira™ Technologies Granted Patent by U.S. Patent Office for the INSPIRA™ ART System's Convertible Dual Lumen Cannula Device and Method of Use

Terumo Cardiovascular is a division of Terumo Corporation, a leading medical device company operating in 160+ countries and regions RA'ANANA, Israel, Dec. 28, 2022 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, announced today that it has signed an exclusive OEM (Original Equipment Manufacturing) agreement with Terumo Cardiovascular, a division of Terumo Corporation, a leading global medical device company.

Inspira™ Technologies Signs Strategic OEM Agreement with Terumo Cardiovascular

ORLANDO, Fla, Dec. 22, 2022 /PRNewswire/ -- RedChip Companies will air an interview with Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, on The RedChip Money Report® on Bloomberg TV, this Saturday, December 24, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.

Inspira™ Technologies Interview to Air on Bloomberg U.S. on the RedChip Money Report®

ORLANDO, FL / ACCESSWIRE / December 22, 2022 / RedChip Companies will air a new interview with Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) (NASDAQ:IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, on The RedChip Money Report® on Bloomberg TV, this Saturday, December 24, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.

Inspira(TM) Technologies Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)

RA'ANANA, Israel, Dec. 20, 2022 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, announced today that it has begun the manufacturing process for the ALICE CPB (Cardiopulmonary Bypass) device (the "ALICE device") to undergo the Verification and Validation phase prior to its planned 2023 submission to the U.S. Food and Drug Administration (FDA) for 510(k) clearance.

Inspira™ Technologies Begins Manufacturing of the ALICE™ CPB Device, ahead of planned 2023 FDA submission

The agreement with Sheba Medical Center, 10th ranked hospital in the world*, to be the first site for the HYLA Blood Sensor's Clinical Study RA'ANANA, Israel , Dec. 14, 2022 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, announced today that it has signed an agreement to conduct a clinical study of the HYLA blood sensor with Sheba Medical Center in Israel.

Inspira™ Technologies Signs Agreement to Conduct Clinical Study of HYLA™ Blood Sensor

As of September 30, 2022, the Company had $16.2 million in cash, cash equivalents, and short-term bank deposits RA'ANANA, Israel , Nov. 23, 2022 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, announced today its financial results for the third quarter ended September 30, 2022.

Inspira™ Technologies Reports Third Quarter 2022 Financial Results

The agreement signed with Innovimed is over a 5-year period, subject to regulatory approvals RA'ANANA, Israel , Nov. 22, 2022 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, announced today that it has signed an exclusive distribution agreement for the HYLA™ Blood Sensor with Innovimed Sp.

Inspira™ Technologies Signs a Strategic Agreement in Europe to potentially provide $26.1 for Deployment of 1,364 HYLA™ Blood Sensors

RA'ANANA, Israel , Nov. 10, 2022 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, announced today that the Israeli Patent Office (ILPO) granted a patent for a key safety component of the INSPIRATM ART system.

InspiraTM Technologies Granted Patent by the Israeli Patent Office for Key Safety Component for the INSPIRATM ART System

Inspira Technologies CTO Daniella Yeheskely-Hayon, Ph.D., will deliver a guest lecture during Physiology & Technology session RA'ANANA, Israel , Nov. 8, 2022 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N.

Inspira™ Technologies to Present Advanced Respiratory Solutions to Key International Leaders at the Annual iECOs Conference in Tel Aviv, Israel

The study team included leading ICU and respiratory specialists from Company's Scientific Advisory Board RA'ANANA, Israel , Sept. 7, 2022 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N.

Inspira™ Technologies Performed HYLA™ Blood Sensor In-Vivo Study, in Preparation of Planned Human Studies

RA'ANANA, ISRAEL , Sept. 1, 2022 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N.

Inspira™ Technologies to Present at the H.C. Wainwright 24th Annual Global Investor Conference

As of June 30, 2022, the Company had $19.2 million in cash RA'ANANA, Israel , Aug. 11, 2022 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, announced today its financial results for the second quarter ended June 30, 2022.

Inspira™ Technologies Reports Second Quarter 2022 Financial Results

RA'ANANA, Israel , July 11, 2022 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the "Company" or "Inspira Technologies") introduces today the "Liby™" System, an advanced form of life support better known by the medical industry as extracorporeal membrane oxygenation (ECMO), used to treat patients with life-threatening heart and lung failure.

Inspira™ Technologies Reveals Next Generation Liby™ ECMO, an Extracorporeal Membrane Oxygenation System, Targeting a $531 Million Global ECMO Market

The agreement signed with Glo-Med Networks for the potential deployment of HYLA™ Blood Sensors over a 3-year period, subject to regulatory approvals RA'ANANA, Israel , July 7, 2022 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, following yesterday's announcement of the development of its new HYLA™ blood sensor, announced today that it has signed an exclusive summary distribution agreement with the U.S. based Glo-Med Networks ("Glo-Med"), for the distribution of the HYLA™ blood sensor device and disposable units across 6 states in the United States (Texas, New Jersey, New York, Florida, North Carlina and South Carolina).

Inspira™ Technologies Signs Strategic Agreement in U.S. to potentially provide $59 million for Inspira for deployment of 3,889 HYLA™ Blood Sensors

Inspira Technologies Oxy BHN Ltd (NASDAQ: IINN) shares closed up76.6% at $2.19 Wednesday after the company announced it developed a non-invasive blood sensor designated to alert real-time change in patients' clinical condition. Inspira's blood sensor, HYLA, is.

Why Inspira Technologies Stock Soared Today

As Inspira Technologies advances a new blood sensor with the potential to change patient outcomes, IINN stock is quickly heading north. The post Why Is Inspira Technologies (IINN) Stock Up 100% Today?

Why Is Inspira Technologies (IINN) Stock Up 100% Today?

HYLA™ blood sensor intends to reduce the need for actual blood samples to be taken from patients RA'ANANA, Israel , July 6, 2022 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, revealed the development of the HYLA™ blood sensor.

Inspira™ Technologies Develops a Non-Invasive Blood Sensor Designed to Alert Real-Time Change in Patients - Potentially Targets $2.5 Billion ABG Market

ORLANDO, FL / ACCESSWIRE / June 30, 2022 / RedChip Companies will air a new C-Level interview with Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) (NASDAQ:IINNW) (the "Company" or "Inspira Technologies") on The RedChip Money Report® on Bloomberg TV, this Saturday, July 2, at 7 p.m.

RedChip Interviews Inspira Technologies' CFO Joe Hayon

As of March 31, 2022, the Company had $21.7 million in cash RA'ANANA, Israel , May 19, 2022 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, announced today its financial results for the first quarter ended March 31, 2022.

Inspira™ Technologies Announces First Quarter 2022 Financial Results

RA'ANANA, Israel, May 3, 2022 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, today announced that the Company will participate in the following events in May:      The Medtech Forum 2022                                                       Format: one-on-one meetings                                    When: May 3-5 Where: Barcelona International Convention Center, Barcelona, Spain Who: Dr. Adi Rizansky Nir, VP of Business Development of Inspira Technologies The 10th EuroELSO Congress 2022                                                     Format: workshops and one-on-one meetings                                 When: May 4-6 Where: Queen Elizabeth II Centre, London, UK Who: Dr. Daniella Yeheskely-Hayon, CTO of Inspira Technologies          Dr. Adi Rizansky Nir, VP of Business Development of Inspira Technologies          Mr.

Inspira™ Technologies to Participate in Upcoming Events in May

RA'ANANA, Israel , April 6, 2022 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira" or the "Company") announced today the execution of a summary distribution agreement with Bepex Ltd.

Inspira Technologies Announces Deployment Agreement in the Israeli Market to Target $15M

RA'ANANA, Israel, March 31, 2022 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW), has released its financial results for 2021 by posting an update on its Investor Relations website.

Inspira Technologies Releases Q4 & FY2021 Financial Results

Inspira Technologies aims to set a new standard of care in the respiratory care industry by introducing its ART system. SAN ANTONIO, Feb. 28, 2022 /PRNewswire/ -- Frost & Sullivan recently analyzed the European artificial respiratory market and, based on its findings, recognizes Inspira Technologies (Nasdaq: IINN/IINNW) with the 2021 Europe Technology Innovation Leadership Award.

Inspira Technologies Applauded by Frost & Sullivan for Minimizing the Need for Invasive Mechanical Ventilation with Its Innovative Technology, the ART™ System

RA'ANANA, Israel, Feb. 28, 2022 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, announced today that it has been awarded the 2021 Europe Technology Innovation Leadership Award in the artificial respiratory market by Frost & Sullivan, a global research consulting firm with extensive experience in growth opportunities.

News for Inspira Technologies Oxy BHN Ltd Stock (IINN)